ArticleJournal of translational medicine2022

SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.

Yong-Ping Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.